TrialBMC infectious diseases2020

Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trial.

Liat Deutsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.